Ledger.Open graph →
SEC Form D · Amendment · filed March 17, 2016

Potenza Therapeutics, Inc

Offering
$38.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David Cordo · Cambridge, MAExecArnold Oronsky · Cambridge, MADirectorSakae Asanuma · Cambridge, MADirectorDaniel Hicklin · Cambridge, MAExec · DirectorLuke Evnin · Cambridge, MADirectorCynthia Seidel-Dugan · Cambridge, MAExecReid Leonard · Cambridge, MAExecDavid S. Rose · New York, NYExecDavid Greenwald · New York, NYExecKyle Sale · Boise, IDDirectorHoward S. Morgan · New York, NYDirectorDavid Cordo · Cambridge, MAExecArthur Dzaghgouni · Grand Cayman, Cayman IslandsExec · DirectorDrew Eldred · Boise, IDExec · DirectorMicah Johnson · Boise, IDExecPete Hartigan · San Francisco, CAExec · DirectorMarc Fussteig · New York, NYDirectorMitchell Vogel · New York, NYExecDavid R. Mchale · Wilton, CTDirectorMatthew J. Arciuolo · Wilton, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗